Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC32H32N6O10 |
InChIKeyOXIPFLHBDVDLDS-UHFFFAOYSA-N |
CAS Registry2244520-98-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | DE | 17 Aug 2018 |